Sanofi Consumer Healthcare India Ltd
Ticker: SANOFICONR
Decent
48/100
☆ Add to Watchlist
Investing Reference
Price
4670.90
Market Cap
10757.37
Debt/Equity
0.0744
ROE %
75.323
PB
39.4043
Promoter %
71.271
Pledge %
0.000
1Y Rev Growth %
31.814
5Y Rev Growth %
NP Margin %
24.542
NP Margin 5Y Avg %
Trading Reference
1M Return %
-10.429
6M Return %
-5.737
1Y Return %
-3.334
% Away 52W High
26.196
% Away 52W Low
2.941
Daily Volume
2057
Investment Verdict
Hold
Score 68/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 25/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Sanofi Consumer Healthcare India Ltd is likely to experience a moderate upside in the medium-term, supported by recent price action bouncing off key support levels and positive volume trends. However, resistance levels may limit significant gains.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
R
Railtel Corporation of India Ltd
Railtel Corporation of India Ltd shows potential in a growing sector with a decent balance sheet, but faces challenges in profitability and execution risks.
View details
J
Jyothy Labs Ltd
Jyothy Labs Ltd shows potential for moderate growth but faces challenges in profitability and valuation. Investors should proceed with caution.
View details
C
CCL Products (India) Ltd
CCL Products shows potential for growth but faces challenges in profitability and valuation metrics.
View details
A
Acutaas Chemicals Ltd
Acutaas Chemicals Ltd shows potential but faces significant challenges in growth consistency and market sentiment.
View details
U
Usha Martin Ltd
Usha Martin Ltd presents a risky investment profile with inconsistent growth and moderate profitability metrics. Caution is advised.
View details
E
Engineers India Ltd
Engineers India Ltd shows potential but faces challenges in growth consistency and market sentiment.
View details
S
Sanofi India Ltd
Sanofi India Ltd shows a decent investment opportunity with a solid business model and growth potential, though some risks remain.
View details
S
SBFC Finance Ltd
SBFC Finance Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised.
View details
P
Prudent Corporate Advisory Services Ltd
Prudent Corporate Advisory Services Ltd shows potential for growth, but investors should be cautious of execution risks and competitive pressures.
View details
W
Westlife Foodworld Ltd
Westlife Foodworld Ltd shows potential for growth in a competitive sector, but faces challenges in profitability and valuation.
View details
W
Welspun Living Ltd
Welspun Living Ltd shows potential in a growing sector, but faces challenges in consistency and valuation.
View details
P
Powergrid Infrastructure Investment Trust
The stock has potential but faces several challenges that could impact future performance.
View details
A
Alivus Life Sciences Ltd
Alivus Life Sciences Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
W
Waaree Renewable Technologies Ltd
Waaree Renewable Technologies Ltd shows potential in a growing sector, but faces challenges in profitability and valuation.
View details
S
Shriram Pistons & Rings Ltd
While Shriram Pistons & Rings Ltd shows potential for stability, it faces challenges in profitability and market dynamics. Caution is advised for new investments.
View details
B
Blackbuck Ltd
Blackbuck Ltd shows potential in a growing sector but faces challenges in profitability and valuation metrics.
View details
Business Overview
Sanofi Consumer Healthcare India Ltd is a leading player in the Indian healthcare market, dedicated to providing high-quality consumer health products. Catering to a diverse audience, including families and individuals seeking effective health solutions, Sanofi focuses on wellness and preventive care. Their commitment to innovation and quality ensures that consumers have access to trusted brands that enhance their everyday health. With a strong portfolio of products, Sanofi plays a crucial role in promoting healthier lifestyles across India.
- Established leader in consumer healthcare
- Focus on wellness and preventive care
- Trusted brands for everyday health
- Innovative solutions tailored for Indian consumers
- Commitment to quality and safety
- Enhancing health and lifestyle across India
Investment Thesis
Sanofi Consumer Healthcare India Ltd stands out due to its strong promoter credibility, positioning it as a reliable investment. The company's digital services are poised for significant growth, tapping into the evolving consumer landscape. Additionally, its attractive valuation compared to peers presents a compelling opportunity for investors seeking solid returns.
- Strong backing from the Sanofi promoter group enhances credibility.
- Robust growth potential in digital services aligns with market trends.
- Attractive valuation offers a competitive edge against peers.
- Established brand presence ensures customer loyalty and market share.
- Focus on innovation supports long-term growth prospects.
Opportunity vs Risk
Opportunities
- Growing demand for health supplements
- Expansion in e-commerce channels
- Strong brand recognition in India
- Innovative product launches
- Rising health awareness among consumers
Risks ⚠️
- Intense competition in healthcare sector
- Regulatory changes affecting operations
- Supply chain disruptions
- Fluctuating raw material costs
- Economic downturn impacting consumer spending
Peer Perspective
Sanofi Consumer Healthcare India Ltd trades at a slight premium to peers like Dabur and Hindustan Unilever, reflecting strong growth potential; however, a focus on margin stability will be crucial for any rerating.
Future Outlook
Sanofi Consumer Healthcare India Ltd is well-positioned for growth, driven by strong brand recognition and expanding market presence. Continued focus on execution and cost control will be crucial to capitalize on emerging opportunities.
AI FAQs for Retail Users
- Q: What does Sanofi Consumer Healthcare India Ltd do?A: Sanofi Consumer Healthcare India Ltd focuses on over-the-counter healthcare products and consumer health solutions.
- Q: Is Sanofi Consumer Healthcare India Ltd a good investment?A: Investment suitability depends on individual financial goals and risk tolerance; consider researching thoroughly.
- Q: What are the key products of Sanofi Consumer Healthcare India Ltd?A: Key products include pain relief, allergy, and digestive health medications.
- Q: How can I buy shares of Sanofi Consumer Healthcare India Ltd?A: Shares can be purchased through a registered stockbroker or online trading platform.
- Q: What factors affect the stock price of Sanofi Consumer Healthcare India Ltd?A: Stock price can be influenced by market trends, company performance, and economic conditions.
📊 Stock Investment Checklist (100 Points)
Sanofi Consumer Healthcare India Ltd • Updated: 2025-09-17 16:30:42
-
10BusinessHighThe consumer healthcare sector is growing, but competition is intense.
-
10GrowthHighConsistent revenue growth observed, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but cash flow is inconsistent.
-
8ValuationHighValuation metrics are slightly above industry average.
-
7BalanceHighModerate debt levels with reasonable liquidity.
-
9GovernanceHighPromoter holding is strong, but some concerns on disclosures.
-
6DriversGoodGrowth drivers exist, but execution risks are notable.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 48 / 100
• Decent
Sanofi Consumer Healthcare India Ltd shows potential but faces challenges in profitability and execution risks.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 80/100
- Governance: 65/100
- Market Confidence: 72/100